The Global Artificial Intelligence In Cardiology Market Size is valued at 789.84 million in 2022 and is predicted to reach 10.18 billion by the year 2031 at a 33.05% CAGR during the forecast period for 2023-2031.
Cardiology's application of machine learning techniques, computer vision, and other AI technologies is called artificial intelligence (AI). Internet of Things (IoT), Precision medicine, and other cutting-edge digital technologies will play a significant role in the future of cardiology.
The development of techniques for the detection of malignant arrhythmias through wearables, precise CVD prediction of results, diagnosis, treatment options, and outcome prediction for patients with heart failure (HF), and non-intrusive examination of coronary artery disease (CAD) all serve as examples of the potential of AI in future cardiology. Furthermore, owing to the high prevalence of cardiovascular disorders, the widespread use of minimally invasive procedures, the availability of reimbursements, the growing senior population, and the strong demand for ongoing, at-home monitoring.
Several of the nation's major market players are also creating new items and technologies to rival those already on the market. Others are purchasing and collaborating with other hot commodities businesses. This is brought on by several elements, including the region's developed healthcare system, quick adoption of cutting-edge technology, and rising regulatory approvals of AI products.
The high illness load and expanding healthcare system in the area are anticipated to accelerate the use of AI in cardiac diagnosis and therapy. The variables listed above are all anticipated to assist the region. AI can also identify a patient's propensity for developing chronic heart diseases, enabling earlier diagnosis and better care planning. The market has benefited from recent large industry transactions and alliances in AI cardiology that have been made, as well as recent significant investments in AI-powered cardiology technologies.
Competitive Landscape:
Some of the artificial intelligence in cardiology market players are:
- IDOVE
- Cardia
- Optronics Limited
- Artery’s Inc.
- Cardiology
- Ultralight
- Dial Imaging Analysis
- Vista AI.
- Viz a
- RSIP Visio
- Clearly, Inc.
Market Segmentation:
Artificial intelligence in the cardiology market is segmented based on components and applications. Artificial intelligence in the cardiology market is divided into software, hardware and services based on components. By application, the market is segmented into cardiac arrhythmias, stroke, ischemic heart disease /CAD and others.
Based On Components, The Software Segment Is A Major Contributor To Artificial Intelligence In The Cardiology Market
The software category is expected to hold a major share in the global artificial intelligence in cardiology market in 2022. This surge can be ascribed to the increased demand for AI-enabled diagnostic tools that diagnose cardiac patients exceptionally accurately. Additionally, this software improves heart analysis and boosts productivity. The demand for AI software in cardiology is increasing due to these causes. Through data analysis, AI-based software improves physician decision-making. The ECG, aided by AI algorithms, has shortened the time it takes to diagnose patients and can detect anomalies. In addition, several software companies have utilized tactics including investment, alliances, and others to strengthen their overall market position.
The Cardiac Arrhythmias Segment Witnessed Growth At A Rapid Rate
The cardiac arrhythmias segment is projected to grow rapidly in the global artificial intelligence in cardiology market. One of the key drivers of the market's development is AI's high accuracy in recognizing arrhythmias. The deployment of AI in arrhythmia applications should increase as a result. Blockages in the arteries, stress, high blood pressure, and sleep apnea are just a few of the causes of arrhythmia. The demand for AI for detecting and treating arrhythmias is further anticipated to increase due to the huge number of people who suffer from these conditions, especially in countries such as the US, Germany, the UK, China, and India.
The North American Artificial Intelligence In The Cardiology Market Holds A Significant Regional Revenue Share
The North American artificial intelligence in the cardiology market is expected to report the highest market share in revenue shortly. The continuous investment in creating AI-based cardiology solutions reflects the potential that manufacturers and cardiologists see in AI, which will favor the market. Significant studies will be required to support its implementation into practice because the advantages to patients must be established, and the diagnostic accuracy in this area must be extraordinarily high.
In addition, Asia Pacific is projected to increase at a rapid rate. Geriatrics are becoming more prevalent, and diseases like cancer and stroke are becoming more common, which has resulted in a rise in the use of AI technology to identify and diagnose ailments. Another key factor propelling the development of AI in cardiology in this region is the rise in investment in startups using artificial intelligence (AI) in healthcare.
Artificial Intelligence In Cardiology Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 789.84 Mn |
|
Revenue forecast in 2031 |
USD 10.18 Bn |
|
Growth rate CAGR |
CAGR of 33.05% from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million, and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Components And Applications |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
IDOVEN; Cardia; Optronics Limited.; Artery’s Inc.; Cardiology; Ultralight; Dial Imaging Analysis; Vista AI; Viz ai; RSIP Vision; Clearly, Inc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
